Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
RenovoRx (RNXT)
NASDAQ:RNXT
Holding RNXT?
Track your performance easily
RNXT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.61 - $2.35
Previous Close$1.43
Volume39.83K
Average Volume (3M)56.12K
Market Cap
$34.32M
Enterprise Value$24.72M
Total Cash (Recent Filing)$9.60M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta2.36
Next Earnings
May 19, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.57
Shares Outstanding24,001,339
10 Day Avg. Volume98,081
30 Day Avg. Volume56,116
Standard Deviation0.49
R-Squared0.01
Alpha0.00287
Financial Highlights & Ratios
Price to Book (P/B)4.72
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-3.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-4.64
Forecast
1Y Price Target
$6.50Price Target Upside374.45% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
RenovoRx News
Ownership Overview
1.90% Insiders
1.02% Mutual Funds
1.77% Other Institutional Investors
95.07% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
RNXT FAQ
What was RenovoRx’s price range in the past 12 months?
RenovoRx lowest stock price was $0.61 and its highest was $2.35 in the past 12 months.
What is RenovoRx’s market cap?
Currently, no data Available
When is RenovoRx’s upcoming earnings report date?
RenovoRx’s upcoming earnings report date is May 19, 2025 which is in 149 days.
How were RenovoRx’s earnings last quarter?
RenovoRx released its earnings results on Nov 14, 2024. The company reported -$0.1 earnings per share for the quarter, beating the consensus estimate of -$0.117 by $0.017.
Is RenovoRx overvalued?
According to Wall Street analysts RenovoRx’s price is currently Undervalued.
Does RenovoRx pay dividends?
RenovoRx does not currently pay dividends.
What is RenovoRx’s EPS estimate?
RenovoRx’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does RenovoRx have?
RenovoRx has 24,001,339 shares outstanding.
What happened to RenovoRx’s price movement after its last earnings report?
RenovoRx reported an EPS of -$0.1 in its last earnings report, beating expectations of -$0.117. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of RenovoRx?
Currently, no hedge funds are holding shares in RNXT
---
RenovoRx Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.50 (374.45% Upside)
$6.50 (374.45% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
131.01%
12-Months-Change
Fundamentals
Return on Equity
-258.95%
Trailing 12-Months
Asset Growth
185.05%
Trailing 12-Months
Company Description
RenovoRx
RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem.
---
RNXT Stock 12 Month Forecast
Average Price Target
$6.50
▲(374.45% Upside)
Technical Analysis
Aileron Therapeutics
―
Actinium Pharmaceuticals
―
Cardiff Oncology
―
TuHURA Biosciences
―
Best Analysts Covering RNXT
1 Year
1 Year Success Rate
2/7 ratings generated profit
1 Year Average Return
-34.60%
reiterated a buy rating last month
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -34.60% per trade.
---